Skip to main content
. 2017 Sep 19;8(5):e01205-17. doi: 10.1128/mBio.01205-17

FIG 5 .

FIG 5 

Proportion of the DENV3 type-specific neutralizing response targeted to the 5J7 epitope up to 4 years after infection in a cohort study design. (A) Neutralizing titers to the rDENV4/3-M14 virus from year 1 through year 4 post-primary DENV3 infection in a cohort study setting. (B) The ratio of the 5J7 epitope neutralizing antibody response (rDENV4/3-M14) to that of the parental DENV3 was analyzed from 1 to 4 years after primary DENV3 infection. (C) Individual trajectories of the DENV4/3-M14/DENV3 proportions from year 1 through year 4 post-primary DENV3 infection. Data are representative of two independent experiments processed in duplicate for each plasma sample. The NT50 and the proportion of the 5J7 response were compared by one-way ANOVA (n = 10); no significant differences were observed.